Shen N, Ffrench P, Guyotat D, Ffrench M, Fiere D, Bryon P A, Dechavanne M
Haemostasis Laboratory, Pasteur Institute of Lyon, France.
Eur J Haematol. 1994 May;52(5):296-301. doi: 10.1111/j.1600-0609.1994.tb00099.x.
Endothelial cell activation during allogeneic bone marrow transplantation, mainly in acute graft-versus-host disease (aGvHD) was studied in 23 recipients and 5 controls using anti-von Willebrand factor (vWF) antibody, antibodies to endothelial leukocyte adhesion molecule-1 (ELAM-1), vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), and anti-HLA-DQ antibody, by immunohistological staining of skin. vWF extravasation, ELAM-1 and VCAM-1 expression were present in most recipients with a cutaneous rash which was confirmed as an aGvHD by histological examination (documented aGvHD) (p = 0.005 for vWF extravasation and ELAM-1 expression and p = 0.03 for VCAM-1 expression in comparison with the controls). In recipients with a rash, the cases displaying vWF extravasation and ELAM-1 expression were significantly more numerous in those with a documented aGvHD than in those without histological features of aGvHD (p = 0.01). vWF extravasation and ELAM-1 occurred concomitantly (p < 0.01). This study demonstrates that, during the course of skin aGvHD following bone marrow transplantation, there is transient expression of ELAM-1 and VCAM-1 by endothelial cells and simultaneous vWF extravasation, indicating an intense inflammation with endothelial cell participation.
采用抗血管性血友病因子(vWF)抗体、抗内皮细胞白细胞黏附分子-1(ELAM-1)抗体、抗血管细胞黏附分子-1(VCAM-1)抗体、抗细胞间黏附分子-1(ICAM-1)抗体以及抗HLA-DQ抗体,通过皮肤免疫组织化学染色,对23例异基因骨髓移植受者和5例对照者在同种异体骨髓移植期间,主要是在急性移植物抗宿主病(aGvHD)中的内皮细胞活化情况进行了研究。vWF外渗、ELAM-1和VCAM-1表达见于大多数有皮疹的受者,经组织学检查证实为aGvHD(记录的aGvHD)(与对照组相比,vWF外渗和ELAM-1表达的p值为0.005,VCAM-1表达的p值为0.03)。在有皮疹的受者中,记录的aGvHD患者中出现vWF外渗和ELAM-1表达的病例明显多于无aGvHD组织学特征的患者(p = 0.01)。vWF外渗和ELAM-1同时出现(p < 0.01)。本研究表明,在骨髓移植后的皮肤aGvHD病程中,内皮细胞有ELAM-1和VCAM-1的短暂表达以及同时发生的vWF外渗,表明存在内皮细胞参与的强烈炎症反应。